Archives
-
Firefly Luciferase mRNA: A Delivery Stress Test
2026-08-23
Firefly Luciferase mRNA is more than a reporter: it can reveal whether an RNA delivery system achieves cytosolic translation. This article connects Cap1, 5-moUTP, and poly(A)-tail design with practical assay interpretation and the emerging nanoparticle strategy described in Advanced Materials.
-
SARS-CoV-2 Release Factors Revealed by RNAi Screening
2026-08-22
Kerr et al. used an arrayed, druggable-genome RNA interference screen with measurements at two timepoints to identify host factors acting across the SARS-CoV-2 replication and reinfection cycle. The study highlights Rab11a-associated vesicular transport as a conserved proviral pathway and shows that pharmacological disruption with CDKI-73 can prevent viral release, while also defining important limits for interpreting host-targeted antiviral strategies.
-
BMS-345541 hydrochloride: IKK Assay Guide
2026-08-21
BMS-345541 hydrochloride enables selective interrogation of IKK-driven NF-κB signaling in inflammation research while supporting apoptosis and cell-cycle studies in T-cell acute lymphoblastic leukemia. This workflow-focused guide connects cytokine suppression, RIPK1-centered cell-death biology, assay design, and practical troubleshooting.
-
Sulforaphane, ROS, and NLRP3 in Colitis
2026-08-21
A 2024 study identifies sulforaphane as a potential modulator of oxidative stress and NLRP3 inflammasome activation in dextran sodium sulfate-induced mouse colitis. By combining an animal model with RAW264.7 macrophage experiments, the work links reduced reactive oxygen species with lower NLRP3-associated inflammatory signaling while defining important limits for translation to human ulcerative colitis.
-
CGP 55845 hydrochloride in Synaptic Assays
2026-08-20
CGP 55845 hydrochloride provides a selective pharmacological handle for separating GABAB receptor signaling from astrocytic GAT-3-driven effects in dentate gyrus experiments. This workflow-centered guide covers concentration planning, electrophysiology, neurotransmitter release modulation, troubleshooting, and cautious extension into glucose-sensing assays.
-
Tetramethylrhodamine ethyl ester perchlorate Guide
2026-08-20
Tetramethylrhodamine ethyl ester perchlorate enables live-cell measurement of mitochondrial membrane potential by microscopy, flow cytometry, and plate-based fluorescence. This guide connects practical TMRE assay design with trichothecene-induced liver injury, helping distinguish mitochondrial depolarization from broader ROS, caspase-3, and ER stress signals.
-
Palbociclib in Gastric Cancer Assembloid Research
2026-08-19
Palbociclib (PD0332991) is more than a cell-cycle inhibitor in advanced tumor models: it can serve as a functional probe of stromal control over drug response. This article translates patient-derived gastric cancer assembloid findings into practical, context-aware assay strategies.
-
Capsazepine as an MCL1 Inhibitor in Breast Cancer
2026-08-19
The reference study identifies capsazepine as a candidate MCL1 inhibitor capable of restoring tamoxifen sensitivity in resistant breast cancer cells. By combining virtual screening, structural modeling, DARTS-based target validation, and apoptosis assays, the authors connect MCL1 engagement with mitochondrial cell death and provide a rationale for combination endocrine therapy.
-
SR-202 PPAR Antagonist: Research Workflows
2026-08-18
SR-202 gives researchers a selective way to test whether PPARγ drives adipogenesis, insulin resistance, and macrophage-state changes rather than merely correlating with them. This workflow-focused guide connects cell assays, DSS-induced intestinal inflammation models, formulation controls, and troubleshooting for translational metabolic research.
-
Pifithrin-α: A Causal Guide to p53 Assays
2026-08-18
Pifithrin-α is a versatile p53 inhibitor for separating p53-dependent apoptosis from ferroptosis and irradiation responses. This assay-focused guide explains how recent neurotoxicology findings can improve experimental design, controls, and interpretation.
-
OMV-Displayed mRNA Antigens for Tumor Vaccination
2026-08-17
The reference study introduces genetically engineered bacterial outer membrane vesicles (OMVs) that rapidly bind box C/D-tagged mRNA antigens and promote their delivery to dendritic cells. By combining RNA capture, lysosomal escape, and innate immune stimulation in one vesicle platform, the work offers a distinct strategy for personalized mRNA tumor vaccination beyond conventional lipid nanoparticles.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-17
The reference study presents chemically modified p21 mRNA packaged in lipid nanoparticles as a localized tumor suppressor replacement strategy for bladder cancer. Its intravesical delivery model produced bladder-focused expression and antitumor activity in an orthotopic mouse model, while also clarifying the experimental and translational questions that remain before clinical evaluation.
-
Sulfo-NHS-LC-Biotin: Practical Protocol Guide
2026-08-16
Sulfo-NHS-LC-Biotin provides stable, water-compatible biotinylation of primary amines on proteins and intact-cell surface proteins for affinity capture or detection. It is appropriate for permanent extracellular labeling, but not for intracellular or reversible biotinylation workflows.
-
OMV-Displayed mRNA Antigens for Tumor Vaccines
2026-08-15
This study developed genetically engineered bacterial outer membrane vesicles (OMVs) that rapidly bind sequence-tagged mRNA antigens and promote their delivery to dendritic cells. The platform combined L7Ae-mediated RNA capture with listeriolysin O-assisted endosomal escape, producing substantial antitumor activity and durable immune memory in mouse models.
-
HyperScript RT SuperMix for qPCR in PDAC Studies
2026-08-14
Translate PDAC mechanisms into reproducible transcript measurements with a premixed workflow designed for structured or scarce RNA. HyperScript RT SuperMix for qPCR combines thermally stable reverse transcription with dual-primer initiation, supporting gene expression analysis across challenging samples and Green dye or probe-based assays.